ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer
View all HER2- Breast Cancer

HER2- Breast Cancer: Videos

5-Year Follow-Up of CALGB 40502 Study in TNBC
5-Year Follow-Up of CALGB 40502 Study in TNBC
Overcoming Resistance in ER+ Breast Cancer
Overcoming Resistance in ER+ Breast Cancer
APHINITY Trial for HER2+ Breast Cancer
APHINITY Trial for HER2+ Breast Cancer
Use of HER2-Targeted Therapy in Breast Cancer
Use of HER2-Targeted Therapy in Breast Cancer
The Prevalence of Brain Metastases in TNBC
The Prevalence of Brain Metastases in TNBC
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.